Cooling in mild encephalopathy (COMET) pilot randomised trial: neurodevelopmental outcomes at two years
Friday, April 24, 2026
5:30pm - 8:00pm ET
Paolo Montaldo, Imperial College London, lONDON, England, United Kingdom; Reema Garegrat, Imperial College London, London, England, United Kingdom; Simona Puzone, University of Campania Luigi Vanvitelli, Naples, Campania, Italy; Anchal Dhawan, Imperial College London, London, England, United Kingdom; Mia Cunliffe, Imperial College London, London, England, United Kingdom; Stuti Pant, Imperial College London, London, England, United Kingdom; Thilipan Thaventhiran, Imperial College London, LONDON, England, United Kingdom; Palaniappan Sashikumar, Medway Maritime Hospital, Gillingham, England, United Kingdom; Santosh Pattnayak, Medway Maritime Hospital, Gillingham, England, United Kingdom; Aung Soe, Medway Hospital, Gillingham, England, United Kingdom; Sundeep Harigopal, Newcastle Upon Tyne NHS Foundation Trust, Newcastle upon Tyne, England, United Kingdom; Balamurugan Palanisami, n, Liverpool, England, United Kingdom; Narendra Aladangady, NHS, London, England, United Kingdom; Seetha Shankaran, University of Texas at Austin Dell Medical School, Ann Arbor, MI, United States; Sudhin Thayyil, Imperial College London, London, England, United Kingdom